Core Viewpoint - The Hong Kong stock market has shown strong performance at the beginning of 2026, boosting market confidence and providing a favorable environment for listed companies to raise funds through refinancing [1][10]. Group 1: Refinancing Activities - As of January 15, 2026, the scale of equity financing (including placements, rights issues, and consideration issues) by Hong Kong listed companies has reached approximately HKD 248.87 billion, a significant increase of HKD 238.67 billion compared to HKD 10.20 billion in the same period of 2025 [3]. - Placement remains the primary method for refinancing among Hong Kong listed companies, with 68% of the 25 refinancing activities initiated by 24 companies opting for this method [3]. - Notable refinancing activities include SF Holding and Jitu Express, which announced a strategic mutual shareholding with a total refinancing amount of HKD 83 billion, marking the largest deal [3]. Group 2: Specific Company Activities - GF Securities raised over HKD 61 billion through H-share placements and convertible bond issuance, ranking second in the refinancing activities this year [4]. - Kanglong Chemical raised approximately HKD 13.34 billion through a placement of new H-shares, ranking third among this year's refinancing projects [4]. - Other companies such as Ying Tai Medical, Black Sesame Intelligence, and YaJie AnKang also raised over HKD 100 million in refinancing [5]. Group 3: Bond Financing Demand - Alongside the surge in equity financing, there is also a strong demand for bond financing in the Hong Kong market [6][10]. - Kuaishou announced plans to issue USD and RMB senior notes, aiming to raise approximately USD 2 billion, with a focus on AI infrastructure development [7]. - JD.com is reportedly considering issuing dim sum bonds with a potential scale of around RMB 10 billion (approximately USD 1.4 billion) [7]. - In 2025, major internet companies like Tencent, Baidu, and Alibaba initiated a wave of bond issuances, indicating a trend towards debt financing in the tech sector [8]. Group 4: Purpose of Fundraising - The active refinancing activities reflect increased confidence in Hong Kong listed companies and the deep integration of capital and industry [10]. - Funds raised are primarily used for international expansion, enhancing research and development, and increasing cash reserves [11]. - Kuaishou's bond proceeds will support its global expansion strategy, while SF Holding and Jitu Express aim to build a more efficient global logistics network [11]. - Crystal Holdings plans to use its bond proceeds to enhance both domestic and international R&D capabilities and expand its business development [11].

Investment Rating - The report maintains a positive outlook on the CXO sector, highlighting growth potential driven by new molecular developments and recovery in domestic market conditions [2]. Core Insights - The CXO sector is experiencing a recovery in demand due to increased research activities and funding from downstream pharmaceutical companies [3][15]. - The macroeconomic environment is improving, with a favorable investment climate for the pharmaceutical and biotechnology sectors as a result of the Federal Reserve's interest rate cuts [6][29]. - Domestic healthcare investment is showing significant growth, with a total investment amount of 93.54 billion yuan in 2025, reflecting an 83.7% year-on-year increase [22][24]. - The number of new drug IND applications in China is steadily increasing, indicating a robust pipeline for future drug development [34][37]. Summary by Sections Macroeconomic Dimension - The Federal Reserve's interest rate cuts are expected to enhance the investment environment for the pharmaceutical sector, benefiting outsourcing demand from pharmaceutical companies [6][29]. - Geopolitical uncertainties are gradually being alleviated, which is expected to positively impact leading CXO companies [3][12]. Industry Dimension - The demand for CXO services is closely linked to the research activities and funding of pharmaceutical companies, with a notable increase in domestic and global investment in healthcare [15][19]. - In 2025, the total investment in China's healthcare sector reached 93.54 billion yuan, with a significant increase in the number of investment events [22][24]. - The number of new drug IND applications in China reached 1,840 in 2025, marking a 15.0% year-on-year increase [34][37]. Company Performance - The CXO sector's revenue for the first three quarters of 2025 was 69.57 billion yuan, representing a 13.0% increase year-on-year, with a net profit of 16.54 billion yuan, up 60.0% [51][57]. - Major contributors to revenue include WuXi AppTec (47%), Kanglong Chemical (15%), and Tigermed (7%) [53][57]. - The overall gross margin for the sector improved to 40.3%, reflecting operational efficiencies and scale effects [51][58].

Core Viewpoint - Kanglong Chemical announced the approval of a proposal to issue new H-shares based on general authorization during the 18th meeting of its third board of directors [1] Group 1 - The board meeting was held on January 15 [1] - The proposal aims to enhance the company's capital structure and support future growth [1]

Market Overview - The Hong Kong stock market experienced a pullback, with the Hang Seng Index closing down 0.28% at 26,923.62 points, and a total trading volume of 290.45 billion HKD [1] - The Hang Seng Tech Index fell by 1.35%, closing at 5,828.35 points, indicating a challenging environment for tech stocks [1] Blue-Chip Stocks Performance - Ctrip Group-S (09961) led the decline among blue-chip stocks, dropping 19.23% to 460 HKD, influenced by an antitrust investigation by the market regulator [2] - BYD Electronics (00285) rose by 3.26%, contributing 1.41 points to the Hang Seng Index, while China Life (02628) fell by 2.87%, detracting 11.17 points from the index [2] Sector Highlights - The technology sector showed mixed results, with Alibaba's stock declining by 2.6% following the launch of its Q&A app, while Baidu gained 0.76% [3] - TSMC announced a significant increase in capital expenditure, projected to reach 56 billion USD in 2026, a 37% increase from 2025, which is expected to benefit the semiconductor industry [4] - The real estate sector saw strong performance, with Vanke Enterprises (02202) rising by 6.85% amid upcoming debt meetings [4] Nickel and Lithium Battery Stocks - Nickel stocks performed well, with LME nickel prices rising by 6.73% to 18,785 USD/ton, driven by potential production quota adjustments in Indonesia [5][6] - Lithium battery stocks also saw gains, with Ganfeng Lithium (01772) increasing by 7.66% as the industry anticipates price increases due to new export tax policies [6] Notable Stock Movements - Dongyao Pharmaceutical-B (01875) surged by 67.6% after a voluntary takeover offer was announced, significantly above its previous closing price [7] - Zhizhu (02513) climbed 11.57% following the announcement of a new AI model in collaboration with Huawei [8] - Jinju Group (02009) issued a profit warning, predicting a net loss of 900 to 1,200 million CNY for 2025, leading to a 6.9% drop in its stock price [9]

Market Overview - The Hang Seng Index fell by 0.55%, down 149 points, closing at 26,850 points, while the Hang Seng Tech Index dropped by 1.83% [1] - The trading volume in the Hong Kong stock market reached HKD 163.9 billion in the morning session [1] Company Highlights - Jiexin International Resources (03858) rose over 5%, reaching a new high as black tungsten ore prices surpassed 500,000 yuan, prompting several tungsten companies to raise long-term contract prices [1] - Likin Resources (02245) increased by over 10% due to disruptions in Indonesian nickel ore quotas, while Zhongwei New Materials (02579) gained over 9% [1] - China Rare Earth Holdings (03788) experienced significant volatility, rising by 8% after announcing the termination of its spin-off listing plan and plans to rename itself "Rare Earth Gold" [1] - Ocean Park Hong Kong (02255) surged over 10%, with visitor numbers on the first day of the New Year holiday increasing by 60% year-on-year [1] - Zhipu (02513) rose over 4% after announcing a collaboration with Huawei to open-source a new generation image generation model [1] - China Heartland Fertilizer (01866) increased by over 4%, anticipating a potential global urea supply shortage, and has been actively repurchasing shares [1] - Woan Robotics (06600) gained over 7% following the release of its humanoid intelligent robot, Onero [1] - Jiantao Laminates (01888) saw a nearly 6% increase after announcing a price hike, which is expected to become a trend in the copper-clad laminate industry [1] - Qiu Tai Technology (01478) declined over 7% as Citigroup reported that the company's net profit last year fell below expectations [1] Other Notable Movements - Kanglong Chemical (03759) dropped over 5% after announcing a placement of shares at an 8.5% discount, aiming to raise nearly HKD 1.32 billion [2] - Trip.com Group (09961) plummeted over 19% due to an investigation by the State Administration for Market Regulation for alleged monopoly practices, while Same City Travel (00780) fell over 11% [2]

Group 1 - The Hang Seng Index fell by 0.55%, down 149 points, closing at 26,850 points, while the Hang Seng Tech Index dropped by 1.83% [1] - Ctrip Group-S experienced a significant decline of over 19% due to an antitrust investigation initiated by the State Administration for Market Regulation [2] - Kaisa International Resources (03858) rose over 5% to reach a new high, with black tungsten concentrate prices surpassing 500,000 yuan, prompting several tungsten companies to raise long-term contract prices [1] Group 2 - Likin Resources (02245) surged over 10% and Zhongwei New Materials (02579) increased by over 9% amid disruptions in Indonesia's nickel ore quotas [1] - China Rare Earth Holdings (03788) saw a significant fluctuation, rising by 8% after the company's plan to spin off its gold business was terminated, and it intends to rename itself "Rare Earth Gold" [1] - Haichang Ocean Park (02255) increased by over 10%, with visitor numbers on the first day of the New Year holiday rising by 60% year-on-year [1] Group 3 - Zhihui (02513) rose over 4% after announcing a collaboration with Huawei to open-source a new generation image generation model [1] - China Heartland Fertilizer (01866) also increased by over 4%, as a global urea supply shortage may arise, and the company is actively repurchasing shares [1] - Woan Robotics (06600) saw a rise of over 7% following the release of its humanoid intelligent robot, Onero [1] Group 4 - Jiantao Laminates (01888) rose nearly 6% during intraday trading after announcing a price increase, which is expected to become a prevailing trend in the copper-clad laminate industry [1] - Q Technology (01478) retracted over 7% after Citigroup reported that the company's net profit last year fell below its expectations [1] - Kanglong Chemical (300759) (03759) dropped over 5% as it plans to conduct a placement at an 8.5% discount, raising nearly 1.32 billion HKD [1]

Group 1 - The company, 康龙化成, experienced a significant decline in its H-shares, dropping by 7.7% [1] - The company plans to issue new H-shares at a discount of 8.5% [1]

Group 1 - The company, 康龙化成 (3759.HK), experienced a significant intraday drop of nearly 8% to HKD 23.02 [1] - The company announced a placement of approximately 58 million new H-shares at a price of HKD 22.82 per share, representing an 8.5% discount to the closing price on Wednesday [1] - The placement shares will account for 3.19% of the total issued shares post-expansion, with the company aiming to raise approximately HKD 1.33 billion for project construction, working capital, and repayment of bank loans and other borrowings [1] Group 2 - The company recently released an earnings forecast, projecting a net profit attributable to shareholders for 2025 to be between RMB 1.614 billion and RMB 1.686 billion, reflecting a year-on-year decline of 6% to 10% [1] - During the reporting period, the company's operating revenue is expected to grow by 13% to 16% year-on-year, while the net profit after excluding non-recurring gains and losses is anticipated to increase by 36% to 41% year-on-year [1]

Market Overview - The Hang Seng Index (HSI) faces short-term resistance at 27,188 points, with expectations of two interest rate cuts in 2026 following the Federal Reserve's December decision to lower rates by 0.25% [2] - The market anticipates increased monetary policy support from mainland China in early 2026, focusing on expanding domestic demand and achieving technological self-reliance [2] - Recent adjustments in financing margin requirements by the Shanghai, Shenzhen, and Beijing stock exchanges may lead to short-term market corrections due to reduced leverage [2] Macro Focus - China's December trade data exceeded expectations, with exports rising by 6.6% and imports by 5.7%, resulting in a trade surplus of 114.14 billion USD [9] - The Chinese Ministry of Industry and Information Technology is regulating industry competition to resist disorderly price wars, particularly in the electric vehicle sector [9] - The Chinese government has extended tax refund policies for home purchases to stimulate the housing market, effective from January 1, 2026, to December 31, 2027 [9] Company News - Baidu is reportedly considering upgrading its Hong Kong listing status to primary listing to attract more mainland investors [11] - Alibaba's AI assistant, Qianwen, is set to release a significant product iteration, with its monthly active users surpassing 100 million [11] - Eastroc Beverage has passed the listing hearing for its IPO in Hong Kong, aiming to enhance its production capacity and brand presence [11] - Kuaishou plans to raise approximately 2 billion USD through its first offshore bond issuance [11] - Trip.com Group is under investigation for alleged monopolistic practices related to its pricing tools affecting hotel partners [11]

Group 1: Market Overview - The Hang Seng Index rose by 151 points, marking its fourth consecutive increase, totaling a gain of 850 points or 3.25% [3][4] - The total market turnover was 340.39 billion, with a net inflow of 2.864 billion from northbound trading [3] - Among the 89 blue-chip stocks, 49 rose while 35 fell, indicating a mixed performance in the market [3] Group 2: Company News - 康龙化成 (CanSino Biologics) announced a placement of 58.44 million new H shares at a price of 22.82 HKD per share, raising approximately 1.334 billion HKD, with 70% of the proceeds allocated for project development [10] - 药明合联 (WuXi AppTec) proposed a cash offer of 4 HKD per share to acquire 东曜制药 (Easton Pharmaceuticals), representing a 60% premium over the last trading price [11] - 中信证券 (CITIC Securities) reported a 38.46% increase in net profit for the fiscal year 2025, reaching 30.051 billion RMB, driven by active market conditions and growth in brokerage and investment banking revenues [12] Group 3: Economic Insights - The Federal Reserve's Beige Book indicated that economic activity in most regions of the U.S. is increasing, with stable employment numbers and moderate price increases [7] - A survey revealed that 32.4% of South Korean companies in South China expect to downsize or withdraw from the market within five years, primarily due to increased competition and rising production costs [8] - The University of Hong Kong's economic policy green paper highlighted new opportunities for Hong Kong's economy, focusing on trade financing, AI, and green finance [9]